Background/Aim: Circulating mRNA can be a useful source of cancer biomarkers. We took
advantage of direct transcriptomic analysis in plasma RNA to identify novel mRNA markers …

Lung cancer (LC) remains associated with significant mortality worldwide. The lack of
reliable noninvasive biomarkers and targeted therapies contributes to poor survival rate …

Background This study aimed to investigate the diagnostic and prognostic role of tumor‐
educated leukocytes (TELs) mRNA in Chinese patients with non‐small cell lung cancer …

Aim We have previously shown that the long noncoding RNA prostate cancer-associated
transcript 6 (PCAT6) promoted the proliferation and invasion of lung adenocarcinoma …

Abstract Background Circulating tumor DNA (ctDNA) has potential as a specific,
noninvasive, and cost‐effective new biomarker for patients with lung cancer. This study …

Objective: Detection of tumor-related mRNA in blood has become a potential cancer
diagnostic approach. However, the sensitivity of single-marker assays is not high enough for …

BACKGROUND: Long intergenic non-coding RNA (lincRNA) belongs to a special type of
RNA that is unable to encode proteins but has been proved to play a role in gene regulation …

The cancer cell secretome may contain potentially useful biomarkers. In this study, we
integrated the profiles of secreted proteins in lung cancer cell lines with mRNA expression …

Background Non-small cell lung cancer (NSCLC) is one of the most prevalent causes of
cancer-related death worldwide. Recently, there are many important medical advancements …

Background RNA sequencing data is providing abundant information about the levels of
dysregulation of genes in various tumors. These data, as well as data based on older …